Aref Zayed
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 4
-
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- Bashar Al-Taani (2 shared papers)Nusaiba K. Al‐Nemrawi (1 shared paper)Nida Alshraiedeh (1 shared paper)Tamam El‐Elimat (6 shared papers)Sahar Hawamdeh (3 shared papers)Tamer Shoeib (2 shared papers)Sarah E. Taylor (2 shared papers)George D.D. Jones (2 shared papers)
- Journals
- Molecules (3 papers)Pharmaceuticals (2 papers)Heliyon (2 papers)Food Bioscience (1 paper)Journal of Young Pharmacists (1 paper)
- Partner nations
- JordanUnited StatesUnited Kingdom
In The Last Decade
Aref Zayed
23 papers receiving 351 citations
Peers
Comparison fields: 5 of 93
- Pharmacology 92
- Pharmaceutical Science 58
- Analytical Chemistry 29
- Biomaterials 38
- Oncology 67
Countries citing papers authored by Aref Zayed
This map shows the geographic impact of Aref Zayed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aref Zayed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aref Zayed more than expected).
Fields of papers citing papers by Aref Zayed
This network shows the impact of papers produced by Aref Zayed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aref Zayed. The network helps show where Aref Zayed may publish in the future.
Co-authors
The 25 scholars most cited alongside Aref Zayed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 69 | |
| 2 | 2008 | 69 | |
| 3 | 2022 | 36 | |
| 4 | 2011 | 29 | |
| 5 | 2010 | 25 | |
| 6 | 2018 | 24 | |
| 7 | 2018 | 19 | |
| 8 | 2020 | 15 | |
| 9 | 2020 | 14 | |
| 10 | 2020 | 11 | |
| 11 | 2020 | 9 | |
| 12 | 2018 | 7 | |
| 13 | 2024 | 6 | |
| 14 | 2020 | 5 | |
| 15 | 2023 | 4 | |
| 16 | 2022 | 4 | |
| 17 | 2022 | 4 | |
| 18 | 2023 | 3 | |
| 19 | 2024 | 1 | |
| 20 | 2021 | 1 |
About Aref Zayed
Aref Zayed is a scholar working on Molecular Biology, Pharmacology, Oncology, Pharmacology and Genetics, having authored 25 papers that have together received 358 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Analytical Methods in Pharmaceuticals (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Cancer Treatment and Pharmacology (2 papers) and Computational Drug Discovery Methods (2 papers). The work is most often cited by research in Pharmacology (92 citations), Pharmaceutical Science (58 citations), Analytical Chemistry (29 citations), Biomaterials (38 citations) and Oncology (67 citations). Aref Zayed has collaborated with scholars based in Jordan, United States and United Kingdom. Frequent co-authors include Bashar Al-Taani, Nusaiba K. Al‐Nemrawi, Nida Alshraiedeh, Tamam El‐Elimat, Sahar Hawamdeh, Tamer Shoeib, Sarah E. Taylor, George D.D. Jones, Barry L. Sharp and Anne Thomas. Their work appears in journals such as Molecules, Pharmaceuticals, Heliyon, Food Bioscience and Journal of Young Pharmacists.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.